SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is surging toward a $1 trillion market valuation as explosive AI demand for memory chips leads analysts to issue aggressive price target upgrades. While bulls celebrate the shift from a cyclical business to a structural AI powerhouse, the community remains divided between those expecting further parabolic gains and others warning of a speculative bubble fueled by extreme FOMO.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Direxion Daily Semiconductor Bear 3X Shares (SOXS) is trending as investors grapple with extreme volatility and the severe decay inherent in the fund amid an unprecedented, AI-fueled rally in semiconductor stocks. The community is heavily focused on debating whether this represents a sustainable bubble or an inevitable correction, while many retail participants report significant losses from attempting to time the top in a sector characterized by parabolic momentum.

Momentus, Inc. engages in the provision of in-space infrastructure services. It offers space transportation and in-orbit servicing. The company was founded by Mikhail Kokorich in 2017 and is headquartered in Santa Jose, CA.

Momentus Inc - Ordinary Shares - Class A

Momentus Inc. is trending as investors aggressively trade the stock amid intense hype surrounding the upcoming SpaceX IPO and potential sector-wide consolidation. While the community is debating the impact of a recent shelf offering and heavy retail volatility, bulls remain focused on the company's defense contracts and its role as a space infrastructure player.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is seeing intense volatility and significant retail FOMO as community members debate whether the parabolic semiconductor rally is a sustainable growth cycle or an AI-driven bubble reaching a climax. Investors are heavily focused on the disconnect between the fund's rapid price appreciation and broader market indicators, with many traders actively debating the merits of holding through potential geopolitical volatility versus capitalizing on historical gains.

Redwire Corp. manufactures and supplies space equipment. It offers critical space solutions and reliability components for the next generation space economy with IP for solar power generation and in-space 3D printing and manufacturing. It assists its customers in solving challenges of future space missions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire Corp is experiencing significant momentum driven by a broader rerating of space-related stocks and excitement surrounding upcoming high-profile industry events. The community is actively debating the stock's parabolic trajectory, with many traders focused on potential short squeezes, institutional interest in its infrastructure backlog, and the company's critical role in NASA's lunar base architecture.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology is trending as investors monitor potential breakout signals ahead of upcoming earnings, with active community discussion centering on the company's expanding AI infrastructure footprint in Southeast Asia and the interplay between its high-growth contract pipeline and ongoing capital structure needs. Traders are closely tracking technical levels and potential short squeeze dynamics, contrasting the company's aggressive business development announcements with concerns regarding dilution risks and operational execution.

Zscaler, Inc. engages in the provision of a cloud-based internet security platform. It offers Zero Trust Exchange, Zscaler Client Connector, Zscaler Internet Access, Zscaler Private Access, Zscaler B2B, Zscaler Cloud Protection, and Zscaler Digital Experience. The company was founded by Jagtar Singh Chaudhry and K. Kailash in September 2007 and is headquartered in San Jose, CA.

Zscaler Inc

Zscaler stock is seeing extreme volatility and a steep sell-off following a mixed Q3 earnings report where better-than-expected earnings were overshadowed by weak revenue guidance and concerns over slowing growth. The community is sharply divided, with bulls viewing the pullback as a buying opportunity given the company's AI-focused security positioning, while bears highlight leadership departures and margin concerns as indicators that the growth story is losing steam.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is under intense pressure as investors navigate a public proxy fight between the board and founder Chip Wilson, while also weighing concerns over leadership changes and heightened competition in the athleisure sector. Community sentiment is deeply polarized, with many retail investors viewing the current valuation as a contrarian buying opportunity despite ongoing technical weakness.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

The iShares Semiconductor ETF is experiencing intense volatility driven by speculative AI-themed trading, with community sentiment deeply polarized between those betting on continued parabolic growth and others warning of a looming dot-com-style bubble pop. Market participants are fixated on high-profile corporate earnings and shifting macroeconomic indicators as they weigh whether this extreme momentum is sustainable or destined for a rapid correction.

Sidus Space, Inc. is a space-as-a-service company. The firm focuses on commercial satellite design, manufacture, launch planning, mission operations and in-orbit support, and data collection with a vision to demonstrate space operations for new technologies, and deliver data and predictive analytics to both domestic and global customers. The company was founded by Carol M. Craig on July 17, 2012 and is headquartered in Merritt Island, FL.

Sidus Space Inc - Ordinary Shares - Class A

Sidus Space is experiencing significant momentum driven by growing investor enthusiasm for the space sector ahead of the highly anticipated SpaceX IPO and recent positive developments in defense-related contracts. The community is actively discussing the stock's potential for a short squeeze and long-term rerating, while debates continue regarding the company's financial outlook and the potential for future equity offerings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ZVRA Found something else. First week of May the EU had a PRAC (risk assessment) meeting and adopted a risk management plan for arimoclomol, which is part of the regular process for new drugs. 
 
https://www.ema.europa.eu/en/documents/agenda/agenda-prac-meeting-4-7-may-2026_en.pdf

Mike Long

Sanford Webb

the original

Steven Hansen

Ethan Curry

Dirk

lance

Whit Gravely

Thurston howell the Third

Mr . E six

Organic Blueberries

Kevin Garofalo

Timothy Cheslock

frank

Robert Lupaka

ChiefTanto

Robert

J. Hoffman

Europa

StockTwits Web

Zevra Therapeutics Inc

 Found something else. First week of May the EU had a PRAC (risk assessment) meeting and adopted a risk management plan for arimoclomol, which is part of the regular process for new drugs. 
 


Robi Trotro

@Robirobi12  
&quot;A Risk Management Plan is a dynamic, proactive document submitted by pharmaceutical companies during a MAA. It outlines a drug&#39;s safety profile, details how known or potential risks will be mitigated, &amp; defines studies to monitor the medicine&#39;s safety once it is on the market.&quot; 
 
&quot;During the pre-authorisation phase of an MAA review, the Pharmacovigilance Risk Assessment Committee  thoroughly evaluates the applicant&#39;s RMP to determine if the drug&#39;s benefits outweigh its risks.&quot;

  
"A Risk Management Plan is a dynamic, proactive document submitted by pharmaceutical companies during a MAA. It outlines a drug's safety profile, details how known or potential risks will be mitigated, & defines studies to monitor the medicine's safety once it is on the market." 
 
"During the pre-authorisation phase of an MAA review, the Pharmacovigilance Risk Assessment Committee  thoroughly evaluates the applicant's RMP to determine if the drug's benefits outweigh its risks."

@Robirobi12  
&quot;The Pre-Authorisation Review Process 
Appointment &amp; Assessment:  
 
&quot;The EMA appoints 2 PRAC members to act as primary evaluators of the RMP alongside the CHMP) rapporteurs.&quot; 
 
LoQs: The PRAC issues feedback, which is consolidated into a list of questions or outstanding issues sent back to the applicant by the CHMP during the 180-day eval period. 
 
Mandating Post-Authorisation Studies: PRAC may require the applicant to commit to a Post-Authorisation Safety Study  as a condition of the marketing authorisation to track specific safety concerns in the broader population. 
 
Final Recommendation: The PRAC adopts an opinion on the RMP, which the CHMP integrates into its final recommendation to the European Commission for marketing approval.

  
"The Pre-Authorisation Review Process 
Appointment & Assessment:  
 
"The EMA appoints 2 PRAC members to act as primary evaluators of the RMP alongside the CHMP) rapporteurs." 
 
LoQs: The PRAC issues feedback, which is consolidated into a list of questions or outstanding issues sent back to the applicant by the CHMP during the 180-day eval period. 
 
Mandating Post-Authorisation Studies: PRAC may require the applicant to commit to a Post-Authorisation Safety Study  as a condition of the marketing authorisation to track specific safety concerns in the broader population. 
 
Final Recommendation: The PRAC adopts an opinion on the RMP, which the CHMP integrates into its final recommendation to the European Commission for marketing approval.

@Robirobi12 My AI states the following: It’s a standard and positive procedural step. All it basically says is that the EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) reviewed and formally adopted Zevra’s proposed Risk Management Plan (RPM) for Arimoclomol (Miplyffa). It is a normal part of the MAA process — the RMP is evaluated in parallel with the main clinical/scientific assessment. It’s routine housekeeping that shows the review is progressing normally. They are preparing the full post-approval safety monitoring framework (which includes how Zevra will track safety, manage risks, and run any required studies after approval).

Thishouseneverwins

Joanne cote

StockTwits for iOS

 My AI states the following: It’s a standard and positive procedural step. All it basically says is that the EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) reviewed and formally adopted Zevra’s proposed Risk Management Plan (RPM) for Arimoclomol (Miplyffa). It is a normal part of the MAA process — the RMP is evaluated in parallel with the main clinical/scientific assessment. It’s routine housekeeping that shows the review is progressing normally. They are preparing the full post-approval safety monitoring framework (which includes how Zevra will track safety, manage risks, and run any required studies after approval).